TRL 382

Drug Profile

TRL 382

Alternative Names: TR-L-382

Latest Information Update: 24 Mar 2016

Price : $50

At a glance

  • Originator Toray
  • Class
  • Mechanism of Action Cyclo-oxygenase 1 inhibitors
  • Orphan Drug Status

    Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.

    No
  • New Molecular Entity Yes

Highest Development Phases

  • Discontinued Neuropathic pain

Most Recent Events

  • 24 Mar 2016 Discontinued - Preclinical for Neuropathic pain in Japan (PO)
  • 21 Oct 2009 Preclinical trials in Neuropathic pain in Japan (PO)
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top